Myriad Genetics said it is in talks with UnitedHealthcare to ensure that enrollees continue to have access to its GeneSight mental health medication test after the insurer changed its coverage policy.

The national tour of the record-setting Broadway yuletide sensation is a special add-on show to the OKC Broadway 2024-2025 ...

Myriad Genetics stock plunges after UnitedHealth Group announces they will no longer cover genetic tests for mental health ...

Quincy Jones, a voracious music lover and jazz musician who played myriad instruments, scored more than 30 films and produced ...

The day after an election is a good day to mention the things that we have in common instead of our divisions.

The company is scheduled to hold its third quarter 2024 earnings conference call after the market closes on Thursday November 7, 2024, and intends to provide additional information regarding its ...

LGBTQ+ voters share their concerns about affordable housing, trans health care, voting rights, and mental health.

Myriad Genetics stock was down 21%, to $17.30, in midday Friday trading. Shares of the diagnostic-test maker have fallen 34% over the past month. Starting Jan. 1, the UnitedHealth Group unit plans to ...

Election Day has finally arrived and in Northeast Ohio, as in the rest of the country, voters are making their way to the ...

Myriad Genetics (NASDAQ:MYGN) is down ~20% in Friday trading following reports that UnitedHealth Group (UNH) will no longer cover the company's genetic test that helps to determine which mental ...

Stephens analyst Mason Carrico notes that Myriad Genetics (MYGN) shares are down about 20% this morning, which the firm blames on an announcement from UnitedHealth (UNH) stating that starting Jan ...

Data-driven decisions rely on quantifiable information, reducing bias and ensuring choices are made based on consistent ...